Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
- PMID: 32349165
- PMCID: PMC7267269
- DOI: 10.1002/uog.22063
Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
Comment on
-
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic.Ultrasound Obstet Gynecol. 2020 Jun;55(6):841-843. doi: 10.1002/uog.22049. Ultrasound Obstet Gynecol. 2020. PMID: 32304612 Free PMC article. No abstract available.
References
-
- Yang M, Ng MH, Li CK. Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology 2005; 10: 101–105. - PubMed
-
- Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum‐Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med 2017; 377: 613–622. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
